Benzinga·2025-09-19 15:39Core Viewpoint - Oscar Health Inc (OSCR) is gaining attention on Wall Street as a potential high-reward investment, particularly in light of discussions surrounding ACA subsidies and a possible government shutdown, drawing comparisons to Hims & Hers Health Inc (HIMS) [1][2]. Group 1: Company Performance and Market Position - Oscar Health has over 80% of its revenue linked to individual plans within the ACA marketplace, with enrollment growth exceeding 40% this year, leading to a revenue outlook of $9.2–$9.3 billion, representing a 50% year-over-year increase [3]. - The company's CEO, Mark Bertolini, believes that the subsidies are unlikely to disappear without causing significant disruption, which may strengthen the likelihood of their extension [4]. - Oscar's profitability outlook into 2026 appears robust if subsidies are maintained, supported by bundled care programs and a growing Hispanic member base [4]. Group 2: Market Dynamics and Technical Indicators - Oscar Health's stock has a short interest of approximately 25% and a relatively low float, creating conditions similar to HIMS, where significant news can lead to rapid stock movements [2]. - Technical indicators suggest a potential short squeeze, with the stock trading above $14 since August, an RSI of 62.14, and bullish MACD indicators. The short interest stands at 24.73%, with trading volume on September 19 spiking to four times the average [5]. - The stock is being closely watched for a breakout at the $25 level, which could trigger significant upward movement if policy developments align favorably [5][6].